| Q37156385 | Amount of HIV DNA in peripheral blood mononuclear cells is proportional to the severity of HIV-1-associated neurocognitive disorders |
| Q36798111 | Better Antiretroviral Central Nervous System Penetration is Not Associated with Reduced Chronic Pain in People Living with Human Immunodeficiency Virus |
| Q34080236 | Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research |
| Q24814874 | Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment |
| Q82029827 | Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex |
| Q35682394 | Clinical implications of HIV-1 drug resistance in the neurological compartment. |
| Q34103216 | Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder |
| Q35731648 | Editorial NeuroAIDS review |
| Q37176655 | Effects of antiretroviral therapy on cognitive impairment |
| Q33994463 | Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles |
| Q33311631 | Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era. |
| Q51760002 | HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication. |
| Q31031123 | HIV and the central nervous system |
| Q37213342 | HIV infection and the central nervous system: a primer |
| Q50200827 | Human Immunodeficiency Virus in the Brain-Culprit or Facilitator? |
| Q36203752 | Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant? |
| Q35112016 | Human immunodeficiency virus-associated dementia: an evolving disease |
| Q33650149 | Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents |
| Q37974980 | Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system |
| Q33283465 | Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy |
| Q44307034 | Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease. |
| Q38906298 | Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells |
| Q35823231 | Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir |
| Q47218999 | Low-level HIV replication in mixed glial cultures is associated with alterations in the processing of p55(Gag). |
| Q37395149 | Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. |
| Q37652087 | Mechanism of blood-retinal barrier breakdown induced by HIV-1 (Review). |
| Q34349192 | Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice |
| Q35065220 | Neurologic aspects of HIV infection in infants and children: therapeutic approaches and outcome |
| Q57787529 | Real-time polymerase chain reaction for diagnosis and management of HIV-induced uveitis |
| Q45415194 | Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients |
| Q37362071 | Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration? |
| Q57294953 | Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir |
| Q31014821 | The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies |
| Q48687135 | Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia. |
| Q37390163 | Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system |
| Q36204440 | Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders |